SRTS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Sensus Healthcare Inc (SRTS).


$113.42M Market Cap.

As of 03/05/2025 5:00 PM ET (MRY) • Disclaimer

SRTS Market Cap. (MRY)


SRTS Shares Outstanding (MRY)


SRTS Assets (MRY)


Total Assets

$62.16M

Total Liabilities

$6.34M

Total Investments

$0

SRTS Income (MRY)


Revenue

$41.81M

Net Income

$6.65M

Operating Expense

$16.34M

SRTS Cash Flow (MRY)


CF Operations

-$831.00K

CF Investing

-$276.00K

CF Financing

$15.00K

SRTS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SRTS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$62,165,000 (15.74%)

$53,710,000 (-5.33%)

$56,735,000 (75.98%)

$32,240,000 (15.10%)

Assets Current

$56,738,000 (14.56%)

$49,528,000 (-6.97%)

$53,241,000 (70.40%)

$31,245,000 (24.13%)

Assets Non-Current

$5,427,000 (29.77%)

$4,182,000 (19.69%)

$3,494,000 (251.16%)

$995,000 (-64.95%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$50,000 (-65.75%)

$146,000 (-56.80%)

Shareholders Equity

$55,827,000 (14.30%)

$48,842,000 (1.61%)

$48,069,000 (84.77%)

$26,015,000 (21.02%)

Property Plant & Equipment Net

$2,578,000 (108.24%)

$1,238,000 (-0.08%)

$1,239,000 (60.08%)

$774,000 (-68.17%)

Cash & Equivalents

$22,056,000 (-4.72%)

$23,148,000 (-9.38%)

$25,544,000 (75.03%)

$14,594,000 (-2.55%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$596,000 (-16.88%)

$717,000 (-13.82%)

$832,000 (-41.98%)

$1,434,000 (-30.76%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$13,444,000 (-9.45%)

$14,847,000 (52.09%)

$9,762,000 (454.97%)

$1,759,000 (-60.27%)

Trade & Non-Trade Receivables

$19,731,000 (85.35%)

$10,645,000 (-38.46%)

$17,299,000 (42.61%)

$12,130,000 (221.24%)

Trade & Non-Trade Payables

$4,811,000 (72.25%)

$2,793,000 (-49.41%)

$5,521,000 (36.05%)

$4,058,000 (41.20%)

Accumulated Retained Earnings (Deficit)

$13,434,000 (97.94%)

$6,787,000 (7.70%)

$6,302,000 (135.12%)

-$17,942,000 (18.67%)

Tax Assets

$2,197,000 (2.66%)

$2,140,000 (24.93%)

$1,713,000 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$37,000 (-95.84%)

$890,000 (0%)

$0 (0%)

Total Debt

$602,000 (-23.12%)

$783,000 (-23.24%)

$1,020,000 (353.33%)

$225,000 (-83.72%)

Debt Current

$204,000 (9.09%)

$187,000 (-1.58%)

$190,000 (-15.56%)

$225,000 (-25.74%)

Debt Non-Current

$398,000 (-33.22%)

$596,000 (-28.19%)

$830,000 (0%)

$0 (0%)

Total Liabilities

$6,338,000 (30.20%)

$4,868,000 (-43.83%)

$8,666,000 (39.21%)

$6,225,000 (-4.44%)

Liabilities Current

$5,885,000 (39.72%)

$4,212,000 (-45.28%)

$7,697,000 (29.08%)

$5,963,000 (22.80%)

Liabilities Non-Current

$453,000 (-30.95%)

$656,000 (-32.30%)

$969,000 (269.85%)

$262,000 (-84.20%)

SRTS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$41,807,000 (71.31%)

$24,405,000 (-45.20%)

$44,532,000 (64.68%)

$27,042,000 (182.36%)

Cost of Revenue

$17,376,000 (67.97%)

$10,345,000 (-30.59%)

$14,904,000 (48.24%)

$10,054,000 (132.30%)

Selling General & Administrative Expense

$12,125,000 (12.64%)

$10,764,000 (-5.05%)

$11,337,000 (20.20%)

$9,432,000 (1.15%)

Research & Development Expense

$4,216,000 (14.63%)

$3,678,000 (6.30%)

$3,460,000 (0.70%)

$3,436,000 (-17.36%)

Operating Expenses

$16,341,000 (13.15%)

$14,442,000 (-2.40%)

$14,797,000 (14.99%)

$12,868,000 (-4.56%)

Interest Expense

$0 (0%)

$0 (0%)

$2,000 (0.00%)

$2,000 (-85.71%)

Income Tax Expense

$2,375,000 (1322.16%)

$167,000 (-95.54%)

$3,746,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$6,647,000 (1270.52%)

$485,000 (-98.00%)

$24,244,000 (488.59%)

$4,119,000 (160.25%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$6,647,000 (1270.52%)

$485,000 (-98.00%)

$24,244,000 (488.59%)

$4,119,000 (160.25%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$6,647,000 (1270.52%)

$485,000 (-98.00%)

$24,244,000 (488.59%)

$4,119,000 (160.25%)

Weighted Average Shares

$16,312,351 (0.33%)

$16,259,254 (-1.35%)

$16,480,991 (0.03%)

$16,476,122 (0.26%)

Weighted Average Shares Diluted

$16,359,616 (0.57%)

$16,266,139 (-2.12%)

$16,618,214 (0.70%)

$16,503,134 (0.42%)

Earning Before Interest & Taxes (EBIT)

$9,022,000 (1283.74%)

$652,000 (-97.67%)

$27,992,000 (579.25%)

$4,121,000 (160.41%)

Gross Profit

$24,431,000 (73.76%)

$14,060,000 (-52.54%)

$29,628,000 (74.41%)

$16,988,000 (223.64%)

Operating Income

$8,090,000 (2217.80%)

-$382,000 (-102.58%)

$14,831,000 (259.98%)

$4,120,000 (150.04%)

SRTS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$276,000 (-47.59%)

-$187,000 (-101.26%)

$14,841,000 (11404.65%)

$129,000 (-98.17%)

Net Cash Flow from Financing

$15,000 (137.50%)

-$40,000 (98.35%)

-$2,428,000 (-951.08%)

-$231,000 (-209.48%)

Net Cash Flow from Operations

-$831,000 (61.26%)

-$2,145,000 (-51.91%)

-$1,412,000 (-393.71%)

-$286,000 (34.10%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$1,092,000 (53.96%)

-$2,372,000 (-121.56%)

$11,001,000 (2935.31%)

-$388,000 (-105.70%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$276,000 (-47.59%)

-$187,000 (-101.26%)

$14,841,000 (11404.65%)

$129,000 (135.93%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$51,000 (76.39%)

-$216,000 (-180.90%)

Issuance (Purchase) of Equity Shares

$67,000 (252.63%)

$19,000 (100.84%)

-$2,268,000 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$323,000 (-1.52%)

$328,000 (75.40%)

$187,000 (-54.94%)

$415,000 (7.51%)

Depreciation Amortization & Accretion

$432,000 (-6.29%)

$461,000 (46.35%)

$315,000 (-48.61%)

$613,000 (-15.10%)

SRTS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

58.40% (1.39%)

57.60% (-13.38%)

66.50% (5.89%)

62.80% (14.60%)

Profit Margin

15.90% (695.00%)

2.00% (-96.32%)

54.40% (257.89%)

15.20% (121.29%)

EBITDA Margin

22.60% (391.30%)

4.60% (-92.77%)

63.60% (263.43%)

17.50% (127.47%)

Return on Average Equity (ROAE)

12.40% (1140.00%)

1.00% (-98.12%)

53.10% (180.95%)

18.90% (161.17%)

Return on Average Assets (ROAA)

11.20% (1144.44%)

0.90% (-97.94%)

43.70% (193.29%)

14.90% (164.22%)

Return on Sales (ROS)

21.60% (700.00%)

2.70% (-95.71%)

62.90% (313.82%)

15.20% (121.35%)

Return on Invested Capital (ROIC)

25.70% (970.83%)

2.40% (-98.69%)

182.60% (256.64%)

51.20% (178.29%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

16.88 (-78.55%)

78.67 (1458.38%)

5.05 (-82.52%)

28.88 (414.25%)

Price to Sales Ratio (P/S)

2.7 (71.76%)

1.57 (-42.75%)

2.75 (-37.58%)

4.4 (-33.59%)

Price to Book Ratio (P/B)

2.03 (156.57%)

0.79 (-69.11%)

2.56 (-44.41%)

4.61 (55.65%)

Debt to Equity Ratio (D/E)

0.11 (14.00%)

0.1 (-44.44%)

0.18 (-24.69%)

0.24 (-21.12%)

Earnings Per Share (EPS)

0.41 (1266.67%)

0.03 (-97.96%)

1.47 (488.00%)

0.25 (159.52%)

Sales Per Share (SPS)

2.56 (70.75%)

1.5 (-44.45%)

2.7 (64.66%)

1.64 (181.48%)

Free Cash Flow Per Share (FCFPS)

-0.07 (52.45%)

-0.14 (-117.55%)

0.81 (8250.00%)

-0.01 (79.17%)

Book Value Per Share (BVPS)

3.42 (13.91%)

3 (2.98%)

2.92 (84.74%)

1.58 (20.72%)

Tangible Assets Book Value Per Share (TABVPS)

3.81 (15.38%)

3.3 (-3.95%)

3.44 (76.54%)

1.95 (15.68%)

Enterprise Value Over EBIT (EV/EBIT)

10 (-65.52%)

29 (866.67%)

3 (-88.00%)

25 (457.14%)

Enterprise Value Over EBITDA (EV/EBITDA)

9.68 (-43.24%)

17.05 (456.81%)

3.06 (-86.04%)

21.94 (369.37%)

Asset Turnover

0.7 (51.07%)

0.47 (-41.97%)

0.8 (-17.81%)

0.98 (200.62%)

Current Ratio

9.64 (-18.01%)

11.76 (70.00%)

6.92 (32.00%)

5.24 (1.10%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$1,107,000 (52.53%)

-$2,332,000 (-117.37%)

$13,429,000 (8653.50%)

-$157,000 (80.20%)

Enterprise Value (EV)

$91,512,153 (382.09%)

$18,982,473 (-78.11%)

$86,714,819 (-16.51%)

$103,861,718 (109.05%)

Earnings Before Tax (EBT)

$9,022,000 (1283.74%)

$652,000 (-97.67%)

$27,990,000 (579.53%)

$4,119,000 (160.25%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$9,454,000 (749.42%)

$1,113,000 (-96.07%)

$28,307,000 (497.95%)

$4,734,000 (177.61%)

Invested Capital

$34,826,000 (28.35%)

$27,133,000 (10.91%)

$24,464,000 (107.99%)

$11,762,000 (27.54%)

Working Capital

$50,853,000 (12.22%)

$45,316,000 (-0.50%)

$45,544,000 (80.14%)

$25,282,000 (24.45%)

Tangible Asset Value

$62,165,000 (15.74%)

$53,710,000 (-5.25%)

$56,685,000 (76.62%)

$32,094,000 (15.98%)

Market Capitalization

$113,419,153 (193.36%)

$38,662,473 (-68.63%)

$123,261,819 (2.74%)

$119,976,718 (88.35%)

Average Equity

$53,516,500 (15.24%)

$46,440,750 (1.68%)

$45,674,000 (109.34%)

$21,818,000 (-1.44%)

Average Assets

$59,364,750 (13.25%)

$52,417,750 (-5.46%)

$55,443,000 (100.32%)

$27,677,500 (-6.01%)

Invested Capital Average

$35,147,500 (28.73%)

$27,302,250 (78.12%)

$15,328,000 (90.27%)

$8,055,750 (-22.81%)

Shares

16,390,051 (0.05%)

16,382,404 (-1.38%)

16,612,105 (-0.03%)

16,617,274 (0.70%)